Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| VACHU | Voyager Acquisition Corp. | $10.75 | $5.26 | 4893.02% | 8 | $340M | $10.21$11.61 |
| SVCO | Silvaco Group | $4.43 | $1.13 | 34.28% | 2.3M | $102M | $3.07$6.57 |
| VEON | Veon | $56.19 | $11.88 | 26.81% | 388.6K | $3.1B | $34.55$64.00 |
| TOI | Oncology Institute | $3.28 | $0.66 | 25.19% | 4.2M | $258M | $0.63$4.88 |
| SHIM | Shimmick | $3.42 | $0.62 | 21.96% | 41.9K | $100M | $1.30$4.47 |
| TAOX | Tao Synergies | $6.15 | $1.09 | 21.54% | 174.5K | $38M | $1.84$11.98 |
| AIFF | Firefly Neuroscience | $2.10 | $0.36 | 20.40% | 107.3K | $25M | $0.62$6.00 |
| CIFG | Themes ETF Trust - Leverage Shares 2x Long Cifr Daily ETF | $7.18 | $1.15 | 19.02% | 61.5K | - | $5.46$16.08 |
| LOCO | El Pollo Loco | $12.91 | $2.03 | 18.61% | 358.1K | $326M | $8.29$13.07 |
| KLXE | KLX Energy Services | $3.09 | $0.42 | 15.73% | 138.1K | $48M | $1.46$4.49 |
| APEI | American Public Education | $54.70 | $7.12 | 14.96% | 623.2K | $860M | $20.75$54.88 |
| EQ | Equillium | $2.37 | $0.30 | 14.52% | 907K | $126M | $0.27$2.49 |
| MRAL | GraniteShares ETF Trust - GraniteShares 2x Long Mara Daily ETF | $3.93 | $0.49 | 14.38% | 1.1M | - | $2.21$36.63 |
| KIDZ | Classover | $2.98 | $0.37 | 14.23% | 12.6M | $1.6M | $2.48$532.50 |
| KRRO | Korro Bio | $13.06 | $1.56 | 13.56% | 8.1K | $108M | $5.20$55.89 |
| NBIG | Themes ETF Trust - Leverage Shares 2x Long Nbis Daily ETF | $9.65 | $1.15 | 13.48% | 597.1K | - | $4.51$19.45 |
| TXXS | Listed Funds Trust - 21Shares 2x Long Sui ETF | $6.23 | $0.73 | 13.33% | 10.4K | - | $4.40$30.70 |
| INVE | Identiv | $3.75 | $0.44 | 13.29% | 244.5K | $79M | $2.86$4.07 |
| KRT | Karat Packaging | $25.27 | $2.96 | 13.27% | 750 | $448M | $20.61$32.68 |
| TXXD | Listed Funds Trust - 21Shares 2x Long Dogecoin ETF | $7.36 | $0.82 | 12.54% | 22.7K | - | $5.94$27.68 |
| NBIL | GraniteShares ETF Trust - GraniteShares 2x Long Nbis Daily ETF | $13.59 | $1.51 | 12.50% | 980.4K | - | $6.37$38.58 |
| SOLT | Volatility Shares Trust - 2x Solana ETF | $57.73 | $6.22 | 12.07% | 171.1K | - | $41.00$706.00 |
| OCGN | Ocugen | $2.62 | $0.28 | 11.75% | 174.6K | $767M | $0.52$2.62 |
| ORKA | Oruka Therapeutics | $35.28 | $3.29 | 10.28% | 129.1K | $1.5B | $5.49$36.53 |
| BDMD | Baird Medical Investment | $2.43 | $0.22 | 9.96% | 230.4K | $81M | $0.76$7.26 |
| EFOI | Energy Focus | $1.85 | $0.07 | 3.93% | 1K | $10M | $1.43$3.56 |
| LFACU | Leapfrog Acquisition Corporation | $10.35 | $0.30 | 2.98% | 239 | $193M | $9.99$10.49 |
| WCT | Wellchange | $3.70 | $0.10 | 2.78% | 713.1 | $10M | $3.03$29.00 |
Related Articles
Featured Article
A Mysterious Stock Has Rallied Over 950% This Year. Here's 1 Key Reason Why Investors Are Turning Bullish
Selena Maranjian|Nov 21, 2025
Over the past 12 months, it has skyrocketed even more -- up in excess of 1,700%.
This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined
Lawrence Rothman, CFA|Oct 21, 2025
Can Oncology Institute's stock continue rewarding investors?
The Motley Fool Interviews Karat Packaging CEO Alan Yu: From Boba Tea Shop to Packaging Powerhouse
Motley Fool Staff|Sep 25, 2025
What began as a single Boba tea shop in 2000 has transformed into a leading supplier of sustainable packaging.
Can Ocugen Stock Keep Churning Higher?
George Budwell, PhD|Apr 29, 2024
This tiny biotech caught fire in 2024. Can it sustain the momentum?
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?
Cory Renauer|Dec 2, 2023
These stocks are coming off a banner month, but what about the road ahead?
1 Reason to Buy Ocugen in 2023 and 2 Reasons to Sell
Adria Cimino|Feb 4, 2023
Ocugen has recently broadened its pipeline.
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
Sean Williams|Jan 23, 2023
Select analysts expect these small-caps stocks to catapult higher in the new year.
Wall Street Thinks This Top 100 Robinhood Stock Could Skyrocket by 217%
Prosper Junior Bakiny|Oct 6, 2022
Can this vaccine maker turn things around?
Here's How This Beaten-Down Stock Could 10X by 2024
Alex Carchidi|Aug 13, 2022
A moonshot won't be necessary, but it'll require a bit of a pivot.
1 Robinhood Stock to Avoid Right Now
Prosper Junior Bakiny|Aug 12, 2022
Popularity is not always a good measure of business performance.
